SNA:NYSESnap-On Incorporated Analysis
Data as of 2026-03-11 - not real-time
$370.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Snap‑On (SNA) trades at $370, sitting below its 20‑day (382) and 50‑day (371) SMAs but above the 200‑day SMA (341), indicating a short‑term pullback within a longer‑term uptrend. RSI at 40.8 points to neutral momentum, while the MACD histogram is negative and the signal line is bearish, adding pressure on the near‑term price. The stock finds support around $361.6 and faces resistance near $390.1, with current volatility of roughly 20% and a beta of 0.73, suggesting modest market sensitivity. On the valuation side, SNA’s trailing PE of 19.3 is well below the industry average of 29.4, yet the DCF‑derived fair value of $202 is dramatically lower than the market price, flagging a potential overvaluation of the equity. Fundamentals remain solid: revenue grew 3.1% YoY, operating margin stands at 25.4%, free cash flow exceeds $640 M, and a dividend yield of 2.64% is backed by a 46% payout ratio. The company’s diversified tool and services platform provides resilient cash flows, supporting dividend sustainability and a stable balance sheet with a debt‑to‑equity of 21.7. Overall, the stock sits at a crossroads where technical weakness meets attractive earnings multiples, while valuation models suggest limited upside beyond the current price.
Given the mixed technical signals, modest volatility, low beta, and strong fundamentals, investors should adopt a cautious stance in the short term, consider buying on any pull‑back, and hold for the medium to long term to capture dividend income and potential valuation correction.
Given the mixed technical signals, modest volatility, low beta, and strong fundamentals, investors should adopt a cautious stance in the short term, consider buying on any pull‑back, and hold for the medium to long term to capture dividend income and potential valuation correction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term SMAs
- Proximity to support at $361.6
- DCF fair value far below market price
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- PE multiple well below industry average
- Strong free cash flow and sustainable dividend
- Diversified business model with resilient demand
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent earnings growth and solid ROE
- Low beta and defensive cash‑flow profile
- Attractive dividend yield with room for payout growth
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin19.72%
P/E Ratio19.3
ROE18.33%
ROA10.03%
Debt/Equity21.71
P/B Ratio3.2
Op. Cash Flow$1.1B
Free Cash Flow$640.3M
Industry P/E29.4
Technical Analysis
TrendBullish
RSI40.8
Support$361.63
Resistance$390.13
MA 20$382.24
MA 50$370.97
MA 200$340.96
MACDBearish
VolumeStable
Fear & Greed Index76.91
Valuation
Fair Value$201.98
Target Price$376.44
Upside/Downside1.74%
GradeOvervalued
TypeBlend
Dividend Yield2.64%
Risk Assessment
Beta0.73
Volatility19.69%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.